Immunic, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective oral immunotherapies for a range of chronic inflammatory and autoimmune conditions.
Immunic stock last closed at $13.39, down 6.23% from the previous day, and has increased 25.14% in one year. It has overperformed other stocks in the Biotechnology industry by 0.43 percentage points. Immunic stock is currently +164.52% from its 52-week low of $5.06, and -15.39% from its 52-week high of $15.83.
As of Jul 24, 2026, there are 13.62M shares of IMUX outstanding. The market value of IMUX is $182.39M. In the past 24 hours, 155,000 IMUX shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy IMUX stock.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, it's time to fill out some personal information so you can buy IMUX stock today.
Now that you have finished signing up on app for stock, your next step is to transfer the money for your investment:
Check out this video walkthrough to see the process of depositing money into your investment account.
Once you have selected the best place to buy Immunic stock, it's absolutely critical to evaluate their stock before you invest, so you can comprehend the risk as well as the opportunity.
WallStreetZen was created to help everyday investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on IMUX's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge IMUX's intrinsic value.
Using relative valuations metrics:
You can access additional valuation research on IMUX's stock here.
Out of 5 Wall Street analysts who research IMUX, the consensus analyst rating on IMUX is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Immunic stock forecast page.
Over the past year, executives and large shareholders at IMUX have not bought or sold any shares.
Dig into more about who owns IMUX shares here.
No, Immunic doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two primary types of orders:
Press the Open button and your broker will place the order.
If you want additional info about buying stocks on eToro, click the helpful video below:
Now that you own some shares in IMUX, you'll want to keep up with your company.
Put IMUX on a watchlist to see the latest developments about your IMUX stock.
To reiterate, here are the 6 steps to buy Immunic stock:
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Immunic, click below.